Why did Tesla shares fall after Musk's new party announcement?
How will Trump's new tariffs affect Japan and South Korea?
What impact will Meta hiring Apple's AI exec have?
Why is CoreWeave acquiring Core Scientific for $9 billion?
How are Amazon and Walmart competing during Prime Day?
What caused Samsung’s large Q2 profit decline?
Why are German companies planning major investments now?
Novartis Gets Swiss Approval For First Malaria Drug For Babies
benzinga.com/news/health-care/25/07/46292859/novartis-gets-swiss-approval-for-first-malaria-drug-for-babies
Swissmedic, the Swiss Agency for Therapeutic Products, approved Novartis AG’s (NYSE:NVS) Coartem (artemether-lumefantrine) Baby on Tuesday. This marks the first malaria medicine specifically approved for newborns and young infants.
The new treatment, also known as Riamet Baby in some…
This story appeared on benzinga.com, 2025-07-08 11:57:32.